Albert Khilevich - Concepedia

Author

Albert Khilevich

Eli Lilly (United States)

Also Known As

A. KHILEVICH, Albert Khilevich, Khilevich, A., Khilevich, Albert

Publications

748

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Southern Research Institute

About

Albert Khilevich is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	292
2	Natural Sciences	4	4	117
3	Biochemistry	4	4	174
4	Health Sciences	1	1	33
5	Social Sciences	1	1	58

Albert Khilevich

Publications

709

Citations

H-Index

Page 1

	Year	Citations
Synthesis, Chromatographic Resolution, and Anti-Human Immunodeficiency Virus Activity of (±)-Calanolide A and Its Enantiomers Michael T. Flavin, John D. Rizzo, Albert Khilevich, Journal of Medicinal Chemistry	1996	214
N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a Novel Metabotropic Glutamate 2 Potentiator with Potential Anxiolytic/Antidepressant Properties: In Vivo Profiling Suggests a Link between Behavioral and Central Nervous System Neurochemical Changes Matthew Fell, Jeffrey M. Witkin, Julie F. Falcone, Journal of Pharmacology and Experimental Therapeutics	2010	99
Structural Analogues of the Calanolide Anti-HIV Agents. Modification of the <i>trans</i>-10,11-Dimethyldihydropyran-12-ol Ring (Ring C) David E. Zembower, Shuyuan Liao, Michael T. Flavin, Journal of Medicinal Chemistry	1997	69
Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8 Kevin M. Gardinier, Douglas L. Gernert, Warren J. Porter, Journal of Medicinal Chemistry Motor ImpairmentSynaptic TransmissionNeuromodulation TherapiesSynaptic SignalingSocial Sciences	2016	58
In vivo anti-HIV activity of (+)-calanolide a in the hollow fiber mouse model Ze‐Qi Xu, Melinda G. Hollingshead, Suzanne Borgel, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryVivo Anti-hiv ActivityMedicineHuman RetrovirusImmunology	1999	57
In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI Ze‐Qi Xu, Robert W. Buckheit, Tracy L. Stup, Bioorganic & Medicinal Chemistry Letters 12-Oxocalanolide AMedicinal ChemistryPharmaceutical ScienceDerivative (Chemistry)Biochemistry	1998	44
Synthesis of pyrazoles and isoxazoles as potent αvβ3 receptor antagonists Thomas D. Penning, Albert Khilevich, Barbara B. Chen, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryMedicinePharmacological AgentPharmacotherapy	2006	38
Synthesis of (+)-calanolide A, an anti-HIV agent, Via enzyme-catalyzed resolution of the aldol products Albert Khilevich, Aye Aye Mar, Michael T. Flavin, Tetrahedron Asymmetry Medicinal ChemistryBioorganic ChemistryVia Enzyme-catalyzed ResolutionBiochemistryNatural Sciences	1996	34
Activation of metabotropic glutamate (mGlu)2 receptors suppresses histamine release in limbic brain regions following acute ketamine challenge Matthew Fell, Jason Katner, Bryan G. Johnson, Neuropharmacology Health SciencesNeurophysiologyMetabotropic GlutamateNeurotransmitterNeuropharmacology	2009	33
Novel approach for synthesis of (±)-calanolide a and its anti-HIV activity A. P. Kucherenko, Michael T. Flavin, William A. Boulanger, Tetrahedron Letters Medicinal ChemistryAnti-hiv ActivityNatural SciencesMedicineNovel Approach	1995	28

Page 1